Work

Gemtuzumab ozogamycin (GO) and toxic mortality (TM) in children and adolescents with acute myeloid leukemia (AML) enrolled on Children’s Oncology Group (COG) trial AAML0531.

Year: 2015

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2015.33.15_suppl.10008

Authors: Jaszianne A. Tolbert, Lillian Sung, Richard Aplenc, Todd Allen Alonzo, Yi-Cheng Jim Wang, Robert B Gerbing, Soheil Meshinchi, Alan S. Gamis

Institutions: Children's Mercy Hospital, Hospital for Sick Children, Children's Hospital of Philadelphia, University of Southern California, Children's Oncology Group, Fred Hutch Cancer Center

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2600768557

Cites:

Cited by:

Related to: 10